Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Gemtuzumab
... > Amino Acids, Peptides, and Proteins > Proteins > Globulins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Gemtuzumab
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Immunoproteins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Gemtuzumab
Carbohydrates > Glycosides > Aminoglycosides > Calicheamicins > Gemtuzumab
... > Organic Chemicals > Hydrocarbons > Hydrocarbons, Acyclic > Alkenes > Enediynes > Calicheamicins > Gemtuzumab
... > Organic Chemicals > Hydrocarbons > Hydrocarbons, Acyclic > Alkynes > Polyynes > Diynes > Enediynes > Calicheamicins > Gemtuzumab

Preferred term

Gemtuzumab  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • CMA 676
  • Gemtuzumab Ozogamicin
  • Mylotarg

Scope note

  • Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.

History note

  • 2020 (2000)

In other languages

URI

http://www.yso.fi/onto/mesh/D000079982

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/8/19, last modified 4/29/19